Please login to the form below

Not currently logged in
Email:
Password:

Genmab hires first chief operating officer

Anthony Mancini joins from Bristol-Myers Squibb

Anthony Mancini

Biotech company Genmab has appointed Anthony Mancini (pictured above) as executive vice president and to the newly created position of chief operating officer.

In his new role, Mancini will oversee all of Genmab’s commercial, corporate development, business development and information technology functions.

He brings both strategic and operational leadership experience to the company, as well as a consistent track record of growth across a number of geographical regions.

Prior to Genmab, Mancini held positions of increasing responsibility in sales, marketing and general management, and has overseen launches and alliances across a range of therapy areas.

Most recently, he led Bristol-Myers Squibb’s US innovative medicines unit, where he managed a team of over 1000 people focused on immunology and cardiovascular diseases.

Mancini will be based in Princeton, New Jersey, US but will also travel regularly to Genmab’s sites in Copehagen, Denmark; Utrecht, The Netherlands; and Tokyo, Japan.

“I am delighted to welcome Anthony to the executive management team in the newly created role of chief operating officer, and look forward to his contributions in building our growing global operations during this transformational stage for Genmab,”said Jan van de Winkel, chief executive officer of Genmab.

“Anthony shares our determination to bring truly differentiated new cancer treatments to the market that will deliver on our commitment to improve patients’ lives while fostering a culture of excellence and passion for innovation,” he added.

Article by
Lucy Parsons

11th March 2020

From: Communique

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics